USPTO serial 79362161
Serial No. 79362161
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 4, 2024
- Examiner
- KUNG, KAELIE ELIZABETH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79362161?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mylab Discovery Solutions Private Limited
IN
Other trademarks owned by Mylab Discovery Solutions Private Limited
Mylab Discovery Solutions Private Limited
IN
Other trademarks owned by Mylab Discovery Solutions Private Limited
Mylab Discovery Solutions Private Limited
IN
Other trademarks owned by Mylab Discovery Solutions Private Limited
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; reagents for scientific purposes for use in nucleic acid isolation and purification; diagnostic biomarkers being reagents for use in assessment of genomic analysis for scientific use; chromatography chemicals; purification preparations in the nature of chemicals for use in the purification of reagents for scientific and research use; chemical reagents for genetic identity testing for nonmedical purposes | ACTIVE | — |
| 005 | Medical diagnostic reagents; drug testing kits containing primarily medical diagnostic reagents and assays for testing body fluids; specimen collection kits for use in virus testing consisting primarily of swabs for medical purposes; veterinary diagnostic reagents; pharmaceutical preparations for diagnostic purposes namely, for diagnosing viral and bacterial infections; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; vaccines; nucleic acid sequences for medical and veterinary purposes; medical diagnostic test strips for biological specimens for blood analysis, urine analysis, saliva analysis; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic biomarkers being reagents for use in assessment of genomic analysis for medical use; diagnostic preparations for medical purposes for detecting mutation in prion genes; pregnancy test kits; nutritional supplements in tablet form; medicines for the treatment of biological diseases diagnosed using reagents in the form of tablets; therapeutic drugs and agents for the treatment of biological diseases diagnosed using reagents; pharmaceutical preparations for the treatment of biological diseases diagnosed using reagents | ACTIVE | — |
| 009 | Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; food analysis apparatus for detection of DNA of adulterant in food; test tubes; DNA microarrays for laboratory use; chromatography equipment for laboratory purposes, namely chromatography columns for use in purification in the laboratory, gas chromatography apparatus for laboratory use; automatic chromatography apparatus for laboratory use; downloadable and recorded computer operating programs; downloadable and recorded software for detecting viral and bacterial infections, genetic sequences; downloadable mobile application software for detecting viral and bacterial infections, genetic sequences; DNA chips; gene amplifiers being laboratory apparatus; laboratory devices for detecting genetic sequences; chromatogram analyzers being apparatus for scientific and laboratory use; centrifuges for laboratory use; laboratory trays; laboratory pipettes; pipette tips for laboratory use; reagent bottles in the nature of laboratory equipment for laboratory use, sold empty | ACTIVE | — |
| 010 | Medical diagnostic apparatus for testing body fluids; testing apparatus for medical purposes for testing body fluids; apparatus for DNA and RNA testing for medical purposes; capillary tubes for samples for medical use; medical devices in the nature of apparatus for taking body fluid samples; analyzers for bacterial identification for medical purposes; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for the detection of abnormal prion protein; in vitro diagnostic testing apparatus incorporating chemical reagents for medical use; face masks for surgical use for anti bacterial protection; diagnostic testing apparatus for use in medical immunoassay procedures; blood sugar testing apparatus for medical diagnostic purposes | ACTIVE | — |
| 042 | Laboratory testing for microbial, chemical, biochemical, bacteriological and medical purposes; pharmaceutical testing ; Laboratory analysis in the field of molecular biology; product design and development of medical diagnostic apparatus; computer-aided diagnostic testing services for others for scientific research purposes; drug discovery services; biomedical research services; research and development services in the field of genomics; research laboratories , namely, providing laboratory research services in the field of bacteriology, virology, chemistry; DNA sequencing for medical research purposes; DNA screening for scientific research purposes; scientific research services relating to the isolation and cultivation of human tissues and cells for others; genetic engineering services, namely, scientific research in the field of genetics and genetic engineering; software as a service (SAAS) services featuring software for detecting viral and bacterial infections, genetic sequences; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; scientific laboratory services in the field of genomics; preparation of biological samples for analysis of body fluids in research laboratories; scientific research services in the field of proteins, antibodies, microorganisms and cells; scientific research for medical purposes in the field of cancerous diseases; testing, inspection and research services in the fields of agriculture, livestock breeding and fisheries; pharmaceutical research | ACTIVE | — |
| 044 | Medical diagnostic services being medical testing and medical analysis for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; disease diagnosis services, namely, consulting services in the field of the diagnosis of disease; medical screening; medical analysis services for diagnostic purposes provided by medical laboratories; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical and health services relating to DNA, genetics and genetic testing, being generic testing for medical purposes; analysis and processing of blood plasma and stem cells being medical services; medical laboratory services for the analysis of samples taken from patients; providing cancer screening services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mylab Discovery Solutions Private Limited
- Other trademarks owned by Mylab Discovery Solutions Private Limited
- Other trademarks owned by Mylab Discovery Solutions Private Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 9, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 9, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 9, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 7, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 16, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 4, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 4, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 10, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 8, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 6, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 5, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |